BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17172171)

  • 1. [Clinicohemadynamic and biochemical the effect of patients with coronary heart disease use combinated lactoovovegetarian diets and simvastatin].
    Medkova IL; Ivanov AN; Mosiakina LI; Biriukova LS
    Vopr Pitan; 2006; 75(5):49-52. PubMed ID: 17172171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of combined lacto-vegetarian diet and selective beta-blocking agents on clinical and metabolic indices in patients with coronary heart disease].
    Ieromuzo AA; Medkova IL; Nemytin IuV; Ivanov AN
    Vopr Pitan; 2012; 81(5):79-82. PubMed ID: 23461177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leveling the hyperlipidemic effect of beta-adrenoblockers by means of antiatherogenic vegetarian diet].
    Medkova IL; Ieromuzo AA; Ivanov AN; Mosiakina LI; Biriukova LS
    Klin Med (Mosk); 2004; 82(6):58-60. PubMed ID: 15344694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.
    Reckless JP; Henry P; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO; Lis K; Brudi P; Allen C
    Int J Clin Pract; 2008 Apr; 62(4):539-54. PubMed ID: 18266852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
    Tikkanen MJ; Holme I; Cater NB; Szarek M; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR;
    Am J Cardiol; 2009 Mar; 103(5):577-82. PubMed ID: 19231315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of an antiatherogenic vegetarian diet on the clinico-hemodynamic and biochemical indices in elderly patients with ischemic heart disease].
    Ivanov AN; Medkova IL; Mosiakina LI
    Ter Arkh; 1999; 71(2):75-8. PubMed ID: 10222562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of coronary heart disease by beta-adrenoblockers or tiazide diuretics preparation in combination with vegetarian diet].
    Medkova IL; Ieromuzo AA; Ivanov AN; Mosiakina LI; Biriukova LS
    Vopr Pitan; 2005; 74(3):39-41. PubMed ID: 16044840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
    Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
    May HT; Anderson JL; Pearson RR; Jensen JR; Horne BD; Lavasani F; Yannicelli HD; Muhlestein JB
    Am J Cardiol; 2008 Feb; 101(4):486-9. PubMed ID: 18312763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Balanced vegetarian diet in combined rehabilitation of patients suffering from ischemic heart disease].
    Medkova IL; Mosiakina LI; Pavlova VE; Zharkov AP; Bugaev VA; Koryshev VI
    Klin Med (Mosk); 1997; 75(1):28-31. PubMed ID: 9082054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four more days.
    Goldstein MR
    Am J Cardiol; 1998 Sep; 82(5):703-4. PubMed ID: 9732913
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
    Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
    Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of early application of simvastatin on C-reactive protein level, blood lipids, and the clinical course of acute coronary syndrome].
    Shal'nev VI
    Klin Med (Mosk); 2007; 85(11):46-50. PubMed ID: 18219956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin exerts its anti-inflammatory effect in hypercholesterolaemic patients by decreasing the serum levels of monocyte chemoattractant protein-1.
    Rallidis LS; Hamodraka ES; Fountoulaki K; Moustogiannis G; Zolindaki MG; Kremastinos DT
    Int J Cardiol; 2008 Feb; 124(2):271-2. PubMed ID: 17399814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart Protection Study].
    Larsen ML; Hildebrandt PR
    Ugeskr Laeger; 2002 Jan; 164(3):348. PubMed ID: 11816337
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program.
    Vossen CY; Hoffmann MM; Hahmann H; Wüsten B; Rothenbacher D; Brenner H
    Clin Pharmacol Ther; 2008 Aug; 84(2):222-7. PubMed ID: 18388879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.